The All-Party Parliamentary Group (APPG) for Prescribed Drug Dependence is pleased to support Public Health England’s announcement of a new evidence review into prescribed drugs that may cause dependence and withdrawal.
Prescribed drug dependence is an escalating issue, with a rising number of prescriptions being issued for addictive and psychoactive substances, including benzodiazepines, antidepressants, z-drugs, gaba-ergic drugs (such as gabapentin), and opioid painkillers. A 2017 study by NatCen revealed that prescriptions for dependence-forming medications increased by 50% between 2000 and 2015, with over 9% of the population using these drugs.[1]
There is substantial evidence that long-term use of these medications can result in severe outcomes, including persistent withdrawal effects that can lead to significant disability. Unlike illicit drugs and alcohol, there are very few publicly funded services available to support those affected.
In 2016, the APPG launched a campaign advocating for a national 24-hour helpline to assist individuals struggling with prescribed drug dependence. This campaign garnered support from major medical bodies, including the BMA, the Royal College of Psychiatrists, the Royal College of GPs, and the Royal College of Physicians.
The APPG is encouraged that Public Health England now acknowledges prescribed drug dependence as a serious public health concern requiring immediate action.
Paul Flynn MP, Chair of the APPG, stated: “Prescribed drug dependence can inflict devastating and prolonged suffering on patients, leading to years of unnecessary hardship and disability following withdrawal from medications prescribed by doctors. We welcome Public Health England’s proposed evidence review as a crucial first step toward establishing services, including a national helpline, to support those affected by this urgent public health issue.”
[1] https://natcen.ac.uk/our-research/research/prescribing-patterns-in-dependence-forming-medicines-2000-2015/
